Skip to main content

Table 4 Nanotechnology designs of co-delivery targeting drugs

From: Nanotechnology approaches to addressing HER2-positive breast cancer

Delivery system HER2 targeting Co-delivery References
Lipid-based nanoparticle Trastuzumab Rapamycin and quantum dots Priyambada Parhi (2015)
pH-sensitive double-emulsion nanocapsule Trastuzumab Magnetic nanoparticles/doxorubicin and paclitaxel Chiang et al. (2014)
Liposomal carrier Targets immune response to breast cancer Doxorubicin and indoximod Lu et al. (2018)